Similarly, multivariate analyses adjusted by age, gender, and any smoking history (Model 1) showed a significant risk reduction by a 1 − SD higher ApoA1 level for total and GI cancer mortalities, while no significant association with lung cancer mortality. This evidence concerns the gene APOA1 and lung cancer.